AI-generated summary
The authors report a meta-analysis of 16 preclinical studies in Alzheimer's disease animal models, which found photobiomodulation was associated with better learning and memory and lower amyloid and p-Tau levels. The authors note high heterogeneity across studies and that translation to humans requires further work and higher-quality preclinical trials.
- Studies included
- 16
- Who or what was studied
- Animal models of Alzheimer's disease
- Wavelengths
- 750 nm
- Limits stated in the abstract
- The abstract reports substantial heterogeneity (I2 = 88%) and calls for further high-quality preclinical trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 750 nm
- Energy density (fluence)
- 3 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Meta-analysis, Photobiomodulation therapy, Systematic review, Cytochrome c oxidase, Oxidative stress, Heterogeneity, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.